Have your own idea? Try our Stock Screener
Swiss (SMI) Biotech Industry Analysis
UpdatedApr 18, 2025
DataAggregated Company Financials
Companies5
- 7D11.1%
- 3M-6.1%
- 1Y54.5%
- YTD-5.5%
All of the companies in the Biotech industry have been up over the last week, with the industry up 11%. In the last 12 months, the industry was up 54%. As for the next few years, earnings are forecast to decline by 9.6% per annum.
Industry Valuation and Performance
Has the Swiss Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 18 Apr 2025 | CHF 1.6b | CHF 411.1m | CHF 65.6m | 4.7x | 24.8x | 4x |
| Sun, 16 Mar 2025 | CHF 1.7b | CHF 409.3m | -CHF 35,110,868.00 | 5.2x | -47.8x | 4.1x |
| Tue, 11 Feb 2025 | CHF 1.9b | CHF 330.3m | -CHF 75,131,868.00 | 3.3x | -26x | 5.9x |
| Thu, 09 Jan 2025 | CHF 1.9b | CHF 330.3m | -CHF 75,131,868.00 | 2.7x | -25.1x | 5.7x |
| Sat, 07 Dec 2024 | CHF 1.6b | CHF 330.9m | -CHF 87,805,465.00 | 1.5x | -17.8x | 4.7x |
| Mon, 04 Nov 2024 | CHF 1.9b | CHF 331.2m | -CHF 86,988,629.00 | 1.7x | -22.1x | 5.8x |
| Wed, 02 Oct 2024 | CHF 1.5b | CHF 333.1m | -CHF 79,869,873.00 | 1.8x | -18.8x | 4.5x |
| Fri, 30 Aug 2024 | CHF 1.4b | CHF 320.8m | -CHF 141,103,264.00 | 1.9x | -10.1x | 4.5x |
| Sun, 28 Jul 2024 | CHF 774.2m | CHF 151.7m | -CHF 146,197,264.00 | 1.6x | -5.3x | 5.1x |
| Tue, 25 Jun 2024 | CHF 771.9m | CHF 151.7m | -CHF 146,197,264.00 | 1.5x | -5.3x | 5.1x |
| Thu, 23 May 2024 | CHF 540.3m | CHF 170.4m | -CHF 131,481,799.34 | 1x | -4.1x | 3.2x |
| Sat, 20 Apr 2024 | CHF 430.2m | CHF 67.2m | -CHF 172,317,273.44 | 0.08x | -2.5x | 6.4x |
| Mon, 18 Mar 2024 | CHF 341.9m | CHF 67.0m | -CHF 173,340,900.02 | 0.3x | -2x | 5.1x |
| Wed, 14 Feb 2024 | CHF 380.4m | CHF 55.6m | -CHF 173,179,321.10 | 1x | -2.2x | 6.8x |
| Fri, 12 Jan 2024 | CHF 339.6m | CHF 317.4m | -CHF 176,081,171.00 | 0.6x | -1.9x | 1.1x |
| Sun, 10 Dec 2023 | CHF 348.6m | CHF 318.0m | -CHF 209,120,197.00 | n/a | -1.7x | 1.1x |
| Tue, 07 Nov 2023 | CHF 285.7m | CHF 318.4m | -CHF 211,122,883.00 | n/a | -1.4x | 0.9x |
| Thu, 05 Oct 2023 | CHF 253.3m | CHF 318.6m | -CHF 213,621,390.00 | n/a | -1.2x | 0.8x |
| Sat, 02 Sep 2023 | CHF 317.3m | CHF 318.5m | -CHF 188,737,917.00 | n/a | -1.7x | 1x |
| Mon, 31 Jul 2023 | CHF 415.5m | CHF 322.5m | -CHF 179,935,255.00 | n/a | -2.3x | 1.3x |
| Wed, 28 Jun 2023 | CHF 303.4m | CHF 330.7m | -CHF 180,755,653.00 | n/a | -1.7x | 0.9x |
| Fri, 26 May 2023 | CHF 335.0m | CHF 332.9m | -CHF 183,398,311.00 | n/a | -1.8x | 1x |
| Sun, 23 Apr 2023 | CHF 430.1m | CHF 480.7m | CHF 8.2m | 1.6x | 52.5x | 0.9x |
| Tue, 21 Mar 2023 | CHF 428.0m | CHF 497.1m | CHF 11.5m | 1.5x | 37.1x | 0.9x |
| Thu, 16 Feb 2023 | CHF 1.1b | CHF 493.4m | CHF 14.5m | 1.7x | 74.3x | 2.2x |
| Sat, 14 Jan 2023 | CHF 512.3m | CHF 493.4m | CHF 14.5m | 1.7x | 35.3x | 1x |
| Mon, 12 Dec 2022 | CHF 508.7m | CHF 493.4m | CHF 14.5m | 1.8x | 35.1x | 1x |
| Wed, 09 Nov 2022 | CHF 521.2m | CHF 506.8m | CHF 14.9m | 1.7x | 35x | 1x |
| Fri, 07 Oct 2022 | CHF 526.2m | CHF 507.3m | CHF 15.9m | 2x | 33.1x | 1x |
| Sun, 04 Sep 2022 | CHF 510.4m | CHF 501.1m | CHF 36.7m | 1.7x | 13.9x | 1x |
| Tue, 02 Aug 2022 | CHF 527.0m | CHF 483.2m | CHF 42.3m | 1.9x | 12.5x | 1.1x |
| Thu, 30 Jun 2022 | CHF 541.8m | CHF 453.9m | CHF 80.7m | 2.2x | 6.7x | 1.2x |
| Sat, 28 May 2022 | CHF 663.3m | CHF 466.3m | CHF 24.4m | 2.1x | 27.2x | 1.4x |
| Mon, 25 Apr 2022 | CHF 1.0b | CHF 295.6m | -CHF 142,004,500.00 | 2x | -7.1x | 3.4x |
Price to Earnings Ratio
-7.1x
Current Industry PE
- Investors are optimistic on the Swiss Biotechs industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 24.8x which is higher than its 3-year average PE of 2.0x.
- The 3-year average PS ratio of 2.7x is lower than the industry's current PS ratio of 4.0x.
Past Earnings Growth
- Total earnings for the Biotechs industry have gone up over the last three years, and the industry is now profitable. Revenues have grown 12% per year.
- This means that more sales are being generated by the industry overall, and subsequently profits are increasing too.
Industry Trends
Which industries have driven the changes within the Swiss Healthcare industry?
| CH Market | 3.50% | |
| Healthcare | 5.15% | |
| Biotech | 11.12% | |
| Biotech | 11.12% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| KURN Kuros Biosciences | CHF 21.00 | 19.0% +CHF 127.5m | 178.5% | PS10.6x | |
| IDIA Idorsia | CHF 1.14 | 14.3% +CHF 32.1m | -41.5% | PS2.3x | |
| BSLN Basilea Pharmaceutica | CHF 41.30 | 3.8% +CHF 18.2m | -1.5% | PE6.5x | |
| SANN Santhera Pharmaceuticals Holding | CHF 14.20 | 7.1% +CHF 11.8m | 51.5% | PE2.8x | |
| MOLN Molecular Partners | CHF 3.16 | 2.3% +CHF 2.6m | -5.7% | PS23.4x |